Sunrest Lifescience Limited (NSEI: SUNREST)
Health Care · Pharmaceuticals · IN
Rs39.90
-1.48% today · -24.6% 1Y
Sunrest Lifescience Limited (NSEI: SUNREST) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.79M and employs 210 people.
Over the last twelve months the share price has lost 24.6%, trading between 29.55 and 57.80.
Tweenvest scores Sunrest Lifescience Limited across four factors: quality 61/100, value 81/100, growth 100/100. Its strongest factor is growth.
SUNREST price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.79M
- Revenue (TTM)
- $7.55M
- P/E
- 4.16
- EPS
- 9.59
- Dividend yield
- —
- Beta (5Y)
- 0.14
- 52-week high
- Rs57.80
- 52-week low
- Rs29.55
- Avg volume (3M)
- —
- Shares outstanding
- 4.29M
- Employees
- 210
- Next earnings
- —
About Sunrest Lifescience Limited
Sunrest Lifescience Ltd. is an India-based pharmaceutical company primarily engaged in the marketing and distribution of a diverse range of healthcare and personal care products within the domestic market. The company operates on an asset-light business model, outsourcing manufacturing to third-party producers and focusing its core competencies on product selection, marketing, and distribution. Its extensive product portfolio includes both over-the-counter (OTC) and prescription-based pharmaceutical formulations, encompassing tablets, capsules, ointments, injectables, syrups, and various other forms. Sunrest Lifescience caters to numerous therapeutic segments, including anti-bacterial, anti-diabetic, anti-fungal, anti-hypertensive, analgesic, nutritional, ayurvedic, and cosmetic products. The company primarily targets consumers in India, with significant market presence and a network of distributors and retailers across states such as Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, and Orissa.
- ISIN
- INE0PLZ01012
- Founded
- 2017
- Listed since
- Nov 20, 2023
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.